INFLUENCE OF METOPROLOL SUCCINATE ON REGULATORY AND ADAPTIVE STATUS OF PATIENTS WITH CHRONIC HEART FAILURE FUNCTIONAL CLASS I. RESULTS OF NOT COMPARATIVE STUDY
https://doi.org/10.20996/1819-6446-2011-7-6-752-756
Abstract
Aim. To estimate metoprolol succinate effect on regulatory and adaptive status (RAS) of patients with сhronic heart failure (CHF) functional class (FC) I and arterial hypertension (HT) I-II stages. Material and methods. 51 patients with CHF FC I and HT I-II stage, (30 men and 21 women aged 52.6±1.4 yeas). Cardio-respiratory synchronism (CRS) test, 6-minute walking test, tread-mill burden test with registration of maximal oxygen consumption, 24-hour blood pressure monitoring, echocardiography and determination of N-terminal pro-brain natriuretic peptide (NT-proBNP) blood level were performed initially and after 6 months of therapy with metoprolol succinate (dose 78.1±5.7 mg/day) in sustained-release presentation. Results. Metoprolol succinate therapy had no significant effect on RAS (there was no unidirectional dynamics of the basic CRS test parameters: a range of synchronization decreased significantly from 8.8±0.4 to 7.2±0.6 сardio-respiratory cycles per minute (in 18%; р<0.05), and duration of CRS development on the minimal boundary from 18.8±2.2 to 14.3±1.2 сardiocycles (in 24%; р<0,05); RAS index considerably did not change), myocardium structure, exercise tolerance and neuro-humoral activity. Metoprolol therapy only moderately improved left ventricle diastolic function. Conclusion. Metoprolol succinate therapy has no significant effect on RAS of patients with CHF FC I and HT I-II stages.
About the Authors
V. G. Tregubov
City Hospital № 2
Russian Federation
Russian Federation
S. G. Kanorskiy
Kuban State Medical University
Russian Federation
Russian Federation
V. M. Pokrovskiy
Kuban State Medical University
Russian Federation
Russian Federation
References
1. Beckett N.S., Peters R., Fletcher A.E. et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med 2008 (18); 358: 1887-1898.
2. Tsutamoto Т., Sakai H., Nishiyama K., et al. Direct comparison of transcardiac increase in brain natriuretic peptide (BNP) and N-terminal proBNP and prognosis in patients with chronic heart failure. Circ J 2007; 71 (12): 1873-1878.
3. Agadzhanyan N.A., Bykov A.T., Trukhanov A.I. Modern technologies of regenerative medicine. Moscow: Meditsina; 2004. Russian (Агаджанян Н.А., Быков А.Т., Труханов А.И. Современные технологии восстановительной медицины. М.: Медицина; 2004).
4. Hypertension: clinical management of primary hypertension in adults. NICE clinical guideline 34. London: National Clinical Guideline Centre; 2011. Available at: http://www.nice.org.uk/nicemedia/live/13561/56007/56007.pdf. Date of access: 16.12.2011.
5. Pokrovskiy V.M. Formation of heart rate in humans and animals. Krasnodar: Kuban'-Kniga; 2007. Russian (Покровский В.М. Формирование ритма сердца в организме человека и животных. Краснодар: Кубань-Книга; 2007).
6. Cohn J.N., Levine T.B., Olivari M.T. et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 1984; 311 (13): 819–823.
7. Dickstein K., Cohen-Solal A., Filippatos G. et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008. The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of cardiology. Developed in collaboration with the Heart Failure Association of ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ES-ICM). Eur Heart J 2008; 10 (10): 933-989.
8. Нernandez A.F., Hammill B.G., O’Connor C.M. et al. Clinical effectiveness of beta-blockers in heart failure: findigs from the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in hospitalized Patients with heart failure) Registry. J Am Coll Cardiol 2009; 53 (2): 184-192.
9. Bristow M.R. ß-Adrenergic receptor blockade in chronic heart failure. Circulation 2000; 101 (5): 558-569.
10. Pokrovsky V.M., Ponomarev V.V., Artyushkov V.V. et al. The system for determining the cardiorespiratory synchronization in humans. Patent №86860. Russia, 2009. Russian (Покровский В.М., Пономарев В.В., Артюшков В.В. и др. Система для определения сердечно-дыхательного синхронизма у человека. Патент № 86860. Россия, 2009).
11. Pokrovskiy V.M. Cardio-respiratory synchronism in the evaluation of regulatory and adaptive capacity of the organism. Krasnodar: Kuban'-Kniga; 2010. Russian (Покровский В.М. Сердечно-дыхательный синхронизм в оценке регуляторно-адаптивных возможностей организма. Краснодар: Кубань-Книга; 2010).
12. Pokrovskiy V.M., Potyagaylo E.G., Abushkevich V.G. et al. cardiorespiratory synchronism: revealing in human dependence on the properties of the nervous system and the functional states of the organism. Uspekhi Fiziologicheskikh Nauk 2003; (3): 68-77. Russian (Покровский В.М., Потягайло Е.Г., Абушкевич В.Г. и др. Сердечно-дыхательный синхронизм: выявление у человека, зависимость от свойств нервной системы и функциональных состояний организма. Успехи физиологических наук 2003; (3): 68-77).
13. Packer M., Bristow M.R., Cohn J.N. et al. Carvedilol Heart Failure Study Group. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 1996; 334 (21): 1349– 1355.
14. Randomised, placebo–controlled trial of carvedilol in patients with congestive heart failure due to is-chaemic heart disease. Australia. New Zealand Heart Failure Research Collaborative Group. Lancet 1997; 349 (9049): 375–380.
15. Belenkov Yu.N., Mareev V.Yu., Ageev F.T. Chronic heart failure. Selected lectures on cardiology. Moscow: GEOTAR–Media; 2006. Russian (Беленков Ю.Н., Мареев В.Ю., Агеев Ф.Т. Хроническая сердечная недостаточность. Избранные лекции по кардиологии. М.: ГЭОТАР–Медиа; 2006).
16. Belenkov Iu.N., Skvortsov A.A., Mareev V.Iu. Clinical, hemodynamic and neurohumoral effects of longterm therapy of patients with severe chronic heart failure with beta-adrenoblocker bisoprolol. Kardiologiia 2003;43(10):10-21. Russian (Беленков Ю.Н., Скворцов А.А., Мареев В.Ю. и др. Клинико– гемодинамические и нейрогуморальные эффекты длительной терапии бета–адреноблокатором бисопрололом больных с тяжелой хронической сердечной недостаточностью. Кардиология 2003; 43 (10): 11–22).
17. Hjalmarson A., Goldstein S., Fagerberg B. et al. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Random-ized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group. JAMA 2000; 283 (10): 1295-1302.
18. Wikstrand J., Warnold I., Tuomilehto J. et al. Metoprolol versus thiazide diuretics in hypertension. Morbidity results from the MAPHY Study. Hypertension 1991; 17 (4): 579-588.
19. Rehnqvist N., Hjemdahl P., Billing E. et al. Treatment of stable angina pectoris with calcium antagonists and beta-blockers. The APSIS study. Angina Prognosis study in Stockholm. Cardiologia 1995; 40 (12): 301.
20. Savonitto S., Ardissiono D., Egstrup K. et al. Combination therapy with metoprolol and nifedipine versus monotherapy in patients with stable angina pectoris. Results of the international multicenter angina exercise (IMAGE) study. J Am Coll Cardiol 1996; 27 (2): 311-316.
21. Chen Z.M., Pan H.C., Chen Y.P. et al. Early intravenous then oral metoprolol in 45852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet 2005; 366 (9497): 1622-1632.
22. The MIAMI Trial Research Group: Metoprolol in acute myocardial infarction (MIAMI): A randomized placebo-controlled international trial. Eur Heart J 1985; 6 (3): 199-226.
23. Hjalmarson A. Effects of beta blockade on sudden cardiac death during acute myocardial infarction and the postinfarction period. Am J Cardiol 1997; 80 (9): 35-39.
Review
For citations:
Tregubov V.G., Kanorskiy S.G., Pokrovskiy V.M. INFLUENCE OF METOPROLOL SUCCINATE ON REGULATORY AND ADAPTIVE STATUS OF PATIENTS WITH CHRONIC HEART FAILURE FUNCTIONAL CLASS I. RESULTS OF NOT COMPARATIVE STUDY. Rational Pharmacotherapy in Cardiology. 2011;7(6):752-756. (In Russ.) https://doi.org/10.20996/1819-6446-2011-7-6-752-756
Views:
555
.jpg)
Email this article 